1. Home
  2. YAAS vs APRE Comparison

YAAS vs APRE Comparison

Compare YAAS & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Youxin Technology Ltd

YAAS

Youxin Technology Ltd

HOLD

Current Price

$1.61

Market Cap

6.6M

Sector

Technology

ML Signal

HOLD

Logo Aprea Therapeutics Inc. Common stock

APRE

Aprea Therapeutics Inc. Common stock

HOLD

Current Price

$0.93

Market Cap

6.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YAAS
APRE
Founded
2018
2006
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
6.9M
IPO Year
2024
2019

Fundamental Metrics

Financial Performance
Metric
YAAS
APRE
Price
$1.61
$0.93
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$20.00
AVG Volume (30 Days)
137.5K
70.0K
Earning Date
07-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$581,862.00
$488,239.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$0.90
52 Week High
$560.00
$5.00

Technical Indicators

Market Signals
Indicator
YAAS
APRE
Relative Strength Index (RSI) 47.69 30.90
Support Level $1.30 $0.90
Resistance Level $2.30 $1.14
Average True Range (ATR) 0.18 0.09
MACD 0.04 -0.01
Stochastic Oscillator 31.00 8.98

Price Performance

Historical Comparison
YAAS
APRE

About YAAS Youxin Technology Ltd

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

Share on Social Networks: